NEUROCUPLE™ in TKA Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This is a randomized (1:1) placebo-controlled clinical trial to determine the feasibility and effectiveness of 30-day application of NEUROCUPLE™ patch for pain reduction and opioid consumption following TKA. Results will establish NEUROCUPLE™ as an effective non-opioid postoperative pain management device for FDA approval. Importantly, we have a placebo device (device without the captor array layer) that looks exactly like the active device, allowing us to conduct a true placebo randomized study.
Epistemonikos ID: 20553db6e27ce7205175c5ad32d8fe7060009fa1
First added on: Jul 01, 2024